Hera News & Events


Humanized Mouse Xenograft Models: The Best of Both Worlds

Xenograft rodent models and cultured cells have long been used [...]

By |November 30th, 2016|

Xenograft Rat Models Give Hope to New Therapeutic Treatments for Leukemia

Mutations in DNA methyltransferase 3A (DNMT3A) are common in acute [...]

By |November 30th, 2016|

Hera BioLabs in Genetic Engineering News

Hera BioLabs and our VP of Research and Development Tseten [...]

By |October 28th, 2016|

Advancements in Stem Cell-Based Therapies for Malignant Brain Tumors

Despite many great developments in the overall treatment of cancers, [...]

By |October 26th, 2016|

Hera BioLabs Receives PHS Approved Animal Welfare Assurance

Hera BioLabs, Inc. (Lexington KY) announced today that it has [...]

By |September 16th, 2016|

Humanized Rodent Models: A Critical Research Tool

Chimeric humanized liver rodent models are being used by those [...]

By |September 16th, 2016|

Lexington based toxicology lab, Hera BioLabs, partners with the NIH to use firefly proteins for drug discovery research

Hera BioLabs, a Lexington based contract research organization (CRO), announced [...]

By |May 10th, 2016|

Hera BioLabs, Inc. licenses SH-SY5Y neuroblastoma cell line and introduced neurotoxicity services

Lexington, KY - February 25, 2016 – Hera BioLabs, Inc. [...]

By |February 25th, 2016|

Hera to exhibit and present at the 2016 SOT ToxExpo

Hera will be located at booth 1103 of the SOT [...]

By |January 28th, 2016|

Solutions & Services

Hera Solutions and Services The quality of pre-clinical translational research [...]

By |November 7th, 2015|